Boehringer Ingelheim USA Corporation
Pharmaceutical company
Based in CT
AI Overview
With $970K in lobbying spend across 21 quarterly filings, Boehringer Ingelheim USA Corporation is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2021 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $170K |
| 2022 | $200K |
| 2023 | $200K |
| 2024 | $200K |
| 2025 | $200K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Boehringer Ingelheim USA Corporation disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Agriculture, Budget/Appropriations, Defense
Issues related to general agriculture issues, animal health, regulatory processes, COVID-19, appropriations
Issues related to general agriculture issues; animal health; regulatory processes; COVID-19
Issues related to FY 2022 appropriations
National Defense Authorization Act; Issues related to animal health
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.